The short version of drug affinity complex fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-05-25. Anything still debated is marked as such rather than presented as settled.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, constructed on the 29-amino-acid fragment designated GRF(1-29). The name began as an internal development code during the 1990s and later spread through research supply catalogs and discussion forums. The molecule does not occur in nature; its sequence is engineered rather than isolated from tissue. Two related compounds are sold under this single label, and they differ by one appended chemical group that strongly influences how long the peptide remains in circulation.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Radiation Source Use and Replacement: Abbreviated Version. National Academies Press. ISBN 978-0-309-11014-3. O'Neil, Marydale J.; Heckelman, Patricia E.; Roman, Cherie B., eds. (2006). The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (14th ed.). Merck Research Laboratories, Merck & Co. ISBN 978-0-911910-00-1. Osborne-Lee, I. W.; Alexander, C. W. (1995). "Californium-252: A Remarkable Versatile Radioisotope". Oak Ridge Technical Report ORNL/TM-12706. doi:10.2172/205871. OSTI 205871. Ruiz-Lapuente, P.; Canal, R.; Isern, J. (1996). Thermonuclear Supernovae. Springer Science+Business Media. ISBN 978-0-7923-4359-2. Seaborg, Glenn T.; Loveland, Walter D. (1990). The Elements Beyond Uranium. John Wiley & Sons, Inc. ISBN 978-0-471-89062-1. Seaborg, Glenn T. (1994). Modern alchemy: selected papers of Glenn T. Seaborg. World Scientific. ISBN 978-981-02-1440-1. Seaborg, Glenn T. (1996). Adloff, J. P. (ed.). One Hundred Years after the Discovery of Radioactivity. Oldenbourg Wissenschaftsverlag. ISBN 978-3-486-64252-0. Seaborg, Glenn T. (2004). "Californium". In Geller, Elizabeth (ed.). Concise Encyclopedia of Chemistry. McGraw-Hill. p. 94. ISBN 978-0-07-143953-4. Szwacki, Nevill Gonzalez; Szwacka, Teresa (2010). Basic Elements of Crystallography. Pan Stanford. ISBN 978-981-4241-59-5. Walker, Perrin; Tarn, William H., eds. (1991). Handbook of Metal Etchants. CRC Press. ISBN 978-0-8493-3623-2. Weeks, Mary Elvira; Leichester, Henry M. (1968). "21: Modern Alchemy". Discovery of the Elements. Journal of Chemical Education. pp. 848–850. ISBN 978-0-7661-3872-8.
The primary emissions of 131I decay are thus electrons with a maximal energy of 606 keV and gammas of 364 keV. Beta decay also produces an antineutrino, which carries off variable amounts of the energy. The electrons, due to their high mean energy (190 keV, with a typical beta-decay spectrum) have a tissue penetration of 0.6 to 2 mm.
=== Women's participation === The Sovereignty Council was mostly male, with two of the eleven members being female: Aisha Musa el-Said and Raja Nicola. At a lower level, Siham Osman was nominated Under-Secretary of the Minister of Justice, and acts on behalf of the Minister of Justice with his authorisation when he is on travels. The Sudanese Women's Union argued that women had played as significant a role as men in the political changes of 2019 and that Sudanese women "claim an equal share of 50-50 with men at all levels, measured by qualifications and capabilities".
==== Surface potential ==== The relation between surface charge and surface potential can be expressed by the Grahame equation, derived from the Gouy-Chapman theory by assuming the electroneutrality condition, which states that the total charge of the double layer must be equal to the negative of the surface charge. Using the one-dimensional Poisson equation and assuming that, at an infinitely great distance, the potential gradient is equal to 0, the Grahame equation is obtained:
Sources: en.wikipedia.org
Lymph contains cellular debris, bacteria, proteins, and lymphocytes, the latter of which are generated largely in the bone marrow and matured or activated in the lymph nodes, spleen, thymus, and tonsils. Lymph also transports antigen-presenting cells, such as dendritic cells, to the lymph nodes where an immune response is stimulated. B cells and T cells are the major types of lymphocytes and are derived from hematopoietic stem cells in the bone marrow. From the bone marrow, B cells immediately join the circulatory system and travel to secondary lymphoid organs in search of pathogens. T cells, on the other hand, travel from the bone marrow to the thymus, where they develop further, mature, and become immunocompetent. In the thymus, T cells are exposed to a wide variety of self-antigens; T cells can only recognize a "non-self" target only after antigens have been processed and presented in combination with the major histocompatibility complex (MHC) self-receptor. In contrast, the B cell antigen-specific receptor is an antibody molecule on the B cell surface, recognising unprocessed antigens (e.g. large molecules found on the surfaces of pathogens; small haptens, such as penicillin, attached to carrier molecules) without any need for antigen processing. Each lineage of B cell expresses a different antibody, so the complete set of B cell antigen receptors represents all the antibodies that the human body can manufacture. The secondary (or peripheral) lymphoid organs (e.g.
== Ultrapure water standards == A number of organizations and groups develop and publish standards associated with the production of UPW. For microelectronics and power, they include Semiconductor Equipment and Materials International (SEMI) (microelectronics and photovoltaic), American Society for Testing and Materials International (ASTM International) (semiconductor, power), Electric Power Research Institute (EPRI) (power), American Society of Mechanical Engineers (ASME) (power), and International Association for the Properties of Water and Steam (IAPWS) (power). Pharmaceutical plants follow water quality standards as developed by pharmacopeias, of which three examples are the United States Pharmacopeia, European Pharmacopeia, and Japanese Pharmacopeia.
Thirlby's Anderson was also highlighted, such as by Berkshire for carrying the film's emotional story and said, "one of the film's true thrills comes in watching Thirlby effortlessly balance the conflict between a Judge's merciless duties and a psychic's compassionate understanding." The New Statesman's Laura Sneddon noted that Dredd passed the Bechdel test, lacking in sexism or misogyny and positively portraying female characters who are no weaker, more sexualised or shown less than their male counterparts. Sneddon described Anderson as repeatedly shown to have power over men who underestimate her, while Ma-Ma displays more intelligence and sadism than any of her male gang members, and neither woman interacts with the other on the basis of their gender. Many US newspaper critics were less taken with the film. Mark Olsen of the Los Angeles Times called it "a clunk-headed action picture" that "simply becomes a monotonous series of bad-guy confrontations". Frank Lovece of Newsday described it as a "soullessly gritty" film, which apart from one believable scene involving Thirlby, is "all tough-guy talk and humorless cynicism". Stephen Whitty of The Star-Ledger called it a "gray and ugly film", said that there was little to draw viewers in, and wrote that apart from the drug-induced slow-motion sequences, the film offers nothing new.
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.